Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer.
Stahel
R A
RA
Division of Oncology, University Hospital Zürich, Switzerland.
Lacroix
H
H
Sculier
J P
JP
Morant
R
R
Richner
J
J
Janzek
E
E
Loibner
H
H
Blythman
H
H
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000628:therapy*; D004341:Drug Evaluation; D006241:Haptens / Q000276:immunology*; D006801:Humans; D007983:Lewis Blood Group Antigens / Q000276:immunology*; D008175:Lung Neoplasms / Q000628:therapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*
D000911:Antibodies, Monoclonal; D006241:Haptens; D007983:Lewis Blood Group Antigens